Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies

References

• Vaupel P , MayerA. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev.26(2), 225–239 (2007).
   PubMed Web of Science ®Google Scholar
• Harris AL . Hypoxia–a key regulatory factor in tumour growth. Nat. Rev. Cancer2(1), 38–47 (2002).
   PubMed Web of Science ®Google Scholar
• Alvarez-Tejado M , Naranjo-SuarezS, JimenezC, CarreraAC, LandazuriMO, Del PesoL. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem.276(25), 22368–22374 (2001).
   PubMed Web of Science ®Google Scholar
• Gately KA , StewartD, WallerD, DaviesA, O'byrneKJ. Phosphorylation and nuclear localisation of Akt is induced by hypoxia and associated with a poor prognosis in malignant pleural mesothelioma. J. Clin. Oncol.26(Suppl. 15S), Abstract 22034 (2008).
   Google Scholar
• Kim TR , ChoEW, PaikSG, KimIG. Hypoxia-induced SM22alpha in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy. FEBS Lett.586(4), 303–309 (2012).
   PubMed Web of Science ®Google Scholar
• Lee SM , LeeCT, KimYW, HanSK, ShimYS, YooCG. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett.242(2), 231–238 (2006).
   PubMed Web of Science ®Google Scholar
• Wennemers M , StegemanH, BussinkJet al. Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer. Int. J. Biol. Markers28(2), e151–e160 (2013).
   PubMed Web of Science ®Google Scholar
• Nijkamp MM , SpanPN, StegemanH, GrenmanR, KaandersJH, BussinkJ. Low phosphorylated AKT expression in laryngeal cancer: indications for a higher metastatic risk. Int. J. Radiat. Oncol. Biol. Phys.87(2), 349–355 (2013).
   PubMed Web of Science ®Google Scholar
• Stegeman H , KaandersJH, WheelerDLet al. Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck. BMC Cancer12(1), 463 (2012).
   PubMedGoogle Scholar
• Merighi S , BeniniA, MirandolaPet al. Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells. Mol. Pharmacol.72(1), 162–172 (2007).
   PubMed Web of Science ®Google Scholar
• Stegeman H , SpanPN, KaandersJH, BussinkJ. Improving chemoradiation efficacy by PI3-K/AKT inhibition. Cancer Treat. Rev.40(10), 1182–1191 (2014).
   PubMed Web of Science ®Google Scholar
• Laughner E , TaghaviP, ChilesK, MahonPC, SemenzaGL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol.21(12), 3995–4004 (2001).
   PubMed Web of Science ®Google Scholar
• Pore N , JiangZ, ShuHK, BernhardE, KaoGD, MaityA. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res.4(7), 471–479 (2006).
   PubMed Web of Science ®Google Scholar
• Meijer TW , KaandersJH, SpanPN, BussinkJ. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin. Cancer Res.18(20), 5585–5594 (2012).
   PubMed Web of Science ®Google Scholar
• Jiang BH , JiangG, ZhengJZ, LuZ, HunterT, VogtPK. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ.12(7), 363–369 (2001).
   PubMedGoogle Scholar
• Gort EH , GrootAJ, Derks Van De VenTLet al. Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas. Oncogene25(45), 6123–6127 (2006).
   PubMed Web of Science ®Google Scholar
• Hirami Y , AoeM, TsukudaKet al. Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1alpha in non-small cell lung cancers. Cancer Lett.214(2), 157–164 (2004).
   PubMed Web of Science ®Google Scholar
• Alvarez-Tejado M , AlfrancaA, AragonesJ, VaraA, LandazuriMO, Del PesoL. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem.277(16), 13508–13517 (2002).
   PubMed Web of Science ®Google Scholar
• Shafee N , KaluzS, RuN, StanbridgeEJ. PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Lett.282(1), 109–115 (2009).
   PubMed Web of Science ®Google Scholar
• Arsham AM , PlasDR, ThompsonCB, SimonMC. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem.277(17), 15162–15170 (2002).
   PubMed Web of Science ®Google Scholar
• Meijer TW , SchuurbiersOC, KaandersJHet al. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4. Lung Cancer76(3), 316–323 (2012).
   PubMed Web of Science ®Google Scholar
• Nijkamp MM , SpanPN, TerhaardCHet al. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. Eur. J. Cancer49(15), 3202–3209 (2013).
   PubMed Web of Science ®Google Scholar
• Mottet D , DumontV, DeccacheYet al. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J. Biol. Chem.278(33), 31277–31285 (2003).
   PubMed Web of Science ®Google Scholar
• Blancher C , MooreJW, RobertsonN, HarrisAL. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res.61(19), 7349–7355 (2001).
   PubMed Web of Science ®Google Scholar
• Vivanco I , SawyersCL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer2(7), 489–501 (2002).
   PubMed Web of Science ®Google Scholar
• Blaustein M , Perez-MunizagaD, SanchezMAet al. Modulation of the Akt pathway reveals a novel link with PERK/eIF2alpha, which is relevant during hypoxia. PLoS ONE8(7), e69668 (2013).
   PubMed Web of Science ®Google Scholar
• Wouters BG , KoritzinskyM. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer8(11), 851–864 (2008).
   PubMed Web of Science ®Google Scholar
• Larsen JE , MinnaJD. Molecular biology of lung cancer: clinical implications. Clin. Chest Med.32(4), 703–740 (2011).
   PubMed Web of Science ®Google Scholar
• Leemans CR , BraakhuisBJ, BrakenhoffRH. The molecular biology of head and neck cancer. Nat. Rev. Cancer11(1), 9–22 (2011).
   PubMed Web of Science ®Google Scholar
• Helfrich BA , RabenD, Varella-GarciaMet al. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. Clin. Cancer Res.12(23), 7117–7125 (2006).
   PubMed Web of Science ®Google Scholar
• Nijkamp MM , HoogsteenIJ, SpanPNet al. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma. Radiother. Oncol.101(1), 165–170 (2011).
   PubMed Web of Science ®Google Scholar